Stockprowler’s pick this week...International BioChemical Industries, Inc. Symbol: OTC BB: IBCL 4405 International Blvd., Suite B-109 Norcross, GA 30093 Phone: (770) 925-3653 Fax: (770) 925-3923 Website: bioshield.com Shares Outstanding: 79.9 million Public Float: 78.9 million Market Capitalization: $11.58 million Closing Price Friday 1/31/03: $0.145
As the United States moves closer to declaring war on Iraq, a nagging and growing fear dominates the American consciousness… what will Sadam Hussein do in retaliation? It is highly likely, given the history of his actions in the previous Gulf War, that Sadam will set ablaze his oil fields and those of neighboring Kuwait, and possibly unleashing chemical or bio-terror weapons to contaminate the sites, and thereby making remediation/ cleanup an incredibly difficult task. Given this possible scenario, Stockprowler.com views the shares of Boots & Coots International Well Control (AMEX: WEL), closing Friday at 53 cents, as a spectacular buying opportunity. Boots & Coots, Inc. is well known for its expertise and significant role in extinguishing the Kuwaiti oil well fires set by the Iraqis during the Gulf War. The company was the subject of a PBS - Nova documentary, “Hellfighters of Kuwait”, released in 1991. Texas based Boots & Coots has a strong strategic alliance with Haliburton (NYSE: HAL). Haliburton routinely assists the company in getting needed equipment and supplies mobilized within 24 hours of an emergency anywhere in the world. Should Sadam execute the aforementioned scenario, shares of WEL could move quickly into the $5 to $10 range on speculative fever. bncg.com
Another stock likely to benefit from Sadam’s actions is U.S. Microbics (OTC BB: BUGSE) trading at under 3 cents a share - and presently not on any analysts’ radar screen. U.S. Microbics creates and markets proprietary microbial technologies that provide natural solutions to many environmental problems. U.S. Microbics’ microbes or "bugs" can be used to break down various substances, including oil, diesel, fuel, arsenic, and certain toxic wastes in water and contaminated soil. Remember you saw it first here. bugsatwork.com
In addition to Sadam Hussein creating havoc with the oil fields in the Middle East, Sadam may very well try to unleash weapons of terror within the borders of the United States. Clearly, given the inadequate border security along our Mexican and Canadian borders, it is highly likely that Iraqi/ Al Qaeda terrorist cells have infiltrated our cities and are prepared to inflict a reign of terror and panic with an easily small/ portable arsenal of biological weapons. Apparently, the U.S. government is taking this potential threat to our homeland security very seriously and has requested an urgent meeting with International BioChemical Industries, Inc. (OTC BB: IBCL). The meeting, which is set for Monday, February 3, 2003, will be for the purpose of discussing test data and company BioShield products that will be effective in the war on bio-terrorism. The discussion will include manufacturing capabilities, good laboratory practices and protocols, security of the facility and security of internal data files including test locations and employee confidentiality. The U.S. Government request is being made after a review by a federal agency of the technical data obtained from the Environmental Protection Agency (EPA). In addition, International BioChemical Industries revealed the discovery of a new proprietary use for its patented technology discovered during testing at a “major university lab.” The facility was engaged by IBCI's distributor, Nova BioGenetics, Inc., to fulfill a request by a pharmaceutical firm to run tests on the product for a specific unnamed disease. Shares of IBCL began running on the news late Friday afternoon closing up 116% at 14.5 cents.
Unlike most other biocides, IBCL’s BioShield’s patented anti-microbial technology is effective against single-celled organisms as it does not dissipate and it minimizes or eliminates the potential for microorganisms to adapt, build up tolerance, or become resistant. It acts by rupturing the cell membrane, not by poisoning the cell. By contrast, other anti-microbials, sanitizers and disinfectants are designed to diffuse and be absorbed. Once absorbed, they act by poisoning the microorganisms or by causing fatal mutations. However, as they diffuse, they lose strength, and adaptation can and usually does occur. Unlike conventional biocides and anti-viral drugs that are designed to volatilize and be absorbed by microorganisms, the BioShield anti-microbial is a durable, broad spectrum anti-microbial that chemically bonds to, and literally becomes part of, the application surface. Most surfaces remain anti-microbial for an extended period of time. BioShield’s anti-microbial acts as microorganisms come into direct contact with it. Since the anti-microbial is not absorbed by organisms, but remains a part of each application surface, it, in effect, transforms conventional surfaces and materials into active anti-microbial surfaces. These surfaces will remain effective for extended periods, which will result in a significant reduction of some viruses and infections caused by air-borne microbial contaminants.
The primary core technology contains no heavy metals, formaldehyde treatment or phenol groups, and is the only essentially non-toxic anti-microbial product on the market. This technology has a unique advantage over all previously known methods and applications: the anti-microbial component material is bonded to the cell or surface. Microorganisms are then destroyed by simple contact with the surface. The BioShield anti-microbial products bond to almost any surface, creating unlimited applications that are unique and cost effective, in addition to being environmentally friendly, and the company has no direct competition within the marketplace.
The technology effectively kills a broad spectrum of microbes and is a revolutionary alternative to conventional sanitizers, disinfectants, or biocides primarily because it kills bacteria, and viruses, including HIV, on contact and can remain active for extended periods of time. Has EPA approval up to 28 day residual kill. See also news of test results on Anthrax: bioshield.com
IBCL had its origins as an antiviral / anti-microbial research and development company that created a new molecule derived from an original Dow Corning Corporation technology. The anti-microbial technology originally created by Dow, before being re-engineered by IBCL, was methanol based, and while effective in killing microorganisms, was highly unstable and poisonous to humans. With the goal of making the compound suitable for human use, Timothy Moses and Jacques Elfersy, co-founders of IBCL, began research at Emory University in 1985 to reengineer the molecule.
On September 21, 1999, the company received its first U.S. Patent for a water stabilized anti-microbial molecule. In February 2000, the company received EPA registration for its concentrated active ingredient, BSTI 1860. By July 2000, the anti-microbial application AM 500 had been approved for direct homeowner use. In September 2000, the company received two additional U.S. patents expanding the current applications of the base technology.
In addition to these three patents, International BioChemical Industries, Inc. has received approval for AM3651PI’s incorporation into and treatment of multiple applications to impart durable microbiostatic protection. The company also plans to seek approval on a modified version of BSTI 1860 that would eliminate the need for methanol, a highly toxic solvent. IBCL also plans to seek EPA and FDA food contact approvals for product usage as preservatives FDA regulated products, including cosmetic articles, hair treatment products, detergents, oils, paints, latex and others.
Depending upon the outcome of discussions with the U.S. Government scheduled to begin on Monday, February 3, 2003, IBCL could easily become the stock of choice by investors eager to latch on to a big winner. I will never forget a biotech stock several years ago that I didn’t buy before the close because I thought it already too hot at $8.00 a share, and then rocketed the next day to $70! When you’re hot, you’re hot… and this could very well be the case here. Just our opinion… Remember, you saw it here on Stockprowler.com.
Stockprowler.com did not receive compensation of any kind from the company or third parties for writing this report. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock.
Good Trading... Stockprowler
Copyright © 2002 Intervast Corp. All rights reserved. | FAQ | Mailbag | Advertise | Disclaimer
stockprowler.com |
